Belvedere Trading
EVLO

Belvedere Trading’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Belvedere Trading’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8,640
Closed -$397K – 630
2022
Q1 		$397K Sell
8,640
-3,417
-28% -$284K 0.01% 133
2021
Q4 		$1.18M Buy
12,057
+5,169
+75% +$873K 0.05% 49
2021
Q3 		$1.13M Buy
+6,888
New +$1.36M 0.03% 49

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Belvedere Trading's EVLO Position: Q2 2022 in Review

Belvedere Trading sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q2 2022, closing a stake of 8,640 shares — an estimated $397K sold.

Belvedere Trading first reported a position in EVLO in Q3 2021 and held it in 3 quarters. The position peaked at $1.18M in Q4 2021. 46 funds tracked by Wall St. Rank hold EVLO as of Q2 2022.

  • Belvedere Trading reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Belvedere Trading sold 8,640 Evelo Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $397K.
  • Belvedere Trading first reported a position in Evelo Biosciences, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Belvedere Trading's Evelo Biosciences, Inc. Common Stock position peaked at $1.18M in Q4 2021.
  • 46 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q2 2022.

Based on Belvedere Trading's 13F filing for Q2 2022, filed 21 Jul 2022.